Stock CHRO CHROMOCELL THERAPEUTICS CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

All News Chromocell Therapeutics Corporation

Equities

CHRO

US1711261057

Market Closed - Nyse
Other stock markets
 04:10:00 2024-05-20 pm EDT 		5-day change 1st Jan Change
1.82 USD +4.00% Intraday chart for Chromocell Therapeutics Corporation -28.06% 0.00%
May. 15 Chromocell Therapeutics Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 16 Chromocell Therapeutics Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Chromocell Therapeutics Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Chromocell To Present at Alliance Global Partner’s Healthcare Company Showcase on Tuesday, May 21, 2024
GL
Chromocell To Present at Alliance Global Partner’s Healthcare Company Showcase on Tuesday, May 21, 2024
AQ
Chromocell Therapeutics Corporation Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Chromocell Issues Letter to Stockholders from Chief Executive Officer
GL
Chromocell Announces Formal Launch of Eye Pain Treatment Program and Hiring of Dr. Simon Chandler
GL
Chromocell Therapeutics Corporation Announces Formal Launch of Eye Pain Treatment Program
CI
Chromocell Names Frank Knuettel as Chief Executive Officer, Removing Interim Status Held Since July 2023
GL
Chromocell Names Frank Knuettel as Chief Executive Officer, Removing Interim Status Held Since July 2023
AQ
Chromocell Therapeutics Corp. Appoints Frank Knuettel, Interim CEO, as Permanent CEO
CI
Transcript : Chromocell Therapeutics Corporation Presents at Sidoti Small-Cap Virtual Conference, Mar-13-2024 02:30 PM
Chromocell to Present at Sidoti Virtual Investor Conference March 13-14
GL
Chromocell to Present at Sidoti Virtual Investor Conference March 13-14
AQ
Benuvia Operations, LLC and Chromocell Therapeutics Corp. Announce Strategic Partnership to Advance Healthcare Solutions
GL
Chromocell Therapeutics Announces Closing of Initial Public Offering for Gross Proceeds of $6.6 Million
GL
Chromocell Therapeutics Corporation has completed an IPO in the amount of $6.6 million.
CI
Chromocell Therapeutics Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Chromocell Therapeutics Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Chromocell Therapeutics Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Chromocell Therapeutics Corporation Reports Earnings Results for the Full Year Ended December 31, 2022
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CHRO Stock
  4. News Chromocell Therapeutics Corporation
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW